Efficacy of 2-DG intervention in COVID-19 as assessed by 6-Minute Walk Test: A case series

Vigg A , Anuradha K


Purpose: To evaluate the effect of 2-deoxy-D-glucose (2-DG) and its impact on the 6-minute walk test (6MWT) in COVID-19 patients before hospital discharge.

Methods: The 6MWT report of the patients hospitalized with acute COVID-19 were analyzed retrospectively. All enrolled patients received 2-DG therapy as an adjunct for ten days to the standard of care in the management of COVID-19. A 6MWT was performed to determine any possible cases of silent hypoxemia before and after 2-DG administration. Data obtained during the tests were compared to evaluate the effect of 2-DG on the clinical condition of the patients and improvement in 6MWT.

Results: A significant improvement in the mean heart rate (86.5 ± 5.6/min, 91.1 ± 5.7/min), Borg scale breathlessness score (2.0 ± 0.5, 2.6 ± 0.7), and fatigue score (1.8 ± 0.6, 2.9 ± 0.6) was observed during the 6MWT post-2-DG therapy. Additionally, an optimum SpO2 level of > 95 % was achieved and maintained post-2-DG therapy compared to the baseline SpO2 level (< 90 %) pre-2-DG therapy. Improvement in these clinical parameters demonstrated a considerable improvement in the mean walking distance by 85% during the 6MWT with a marked development in the number of laps, speed, and metabolic equivalent (METS) compared to results obtained before 2-DG therapy.

Conclusion: 2-DG, as an adjunct therapy improved the clinical condition by achieving an optimum oxygen saturation level (> 95 %) in moderate to severely ill COVID-19 patients. It exhibited a positive impact on the 6MWT by improving the mean walking distance. 6MWT may be useful and can be considered as an effective tool to differentiate the hypoxemic patients before hospital discharge.

More Publications

Enhancing Healthcare Decision-Making: Comparison Between Health Technology Assessments and Access to Medical Care in a High-income Country vs. Low/middle Income Countries

Shashwati P , Arya K , Jignesh B , Guruprasad Rao KS

Mar, 2024

Health Technology Assessment (HTA) in Action

Advances in neuropathic pain management: A review of real-world studies

Swati S. Dash , Nikhil K. Khatri , Divyateja Saraswathi , Jignesh Bhate , Guruprasad Rao KS

Apr, 2024

Journal of Current Research in Scientific Medicine

Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study

Emmy Graber , Hilary E. Baldwin , Richard G. Fried , Evan A. Rieder , Adelaide A. Hebert , James Del Rosso , Leon Kircik , Linda Stein Gold , Julie C. Harper , Andrew F. Alexis , Siva Narayanan , Volker Koscielny , Ismail Kasujee

Feb, 2024

Journal of Drugs in Dermatology (JDD)